Cliniques universitaires Saint-Luc Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00634777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Cliniques universitaires Saint-Luc | Cliniques universitaires Saint-Luc (UCL) | Cliniques Universitaires St-Luc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Carcinoid Tumor (Phase 4)

Malignant Carcinoid Syndrome (Phase 4)

Neuroendocrine Tumors (Phase 4)

Serotonin Syndrome (Phase 4)

Syndrome (Phase 4)

Triple Negative Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 15